Search Results - "Chausse, Guillaume"
-
1
Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods
Published in Journal of Alzheimer's disease (01-01-2021)“…Advanced machine learning methods can aid in the identification of dementia risk using neuroimaging-derived features including FDG-PET. However, to enable the…”
Get more information
Journal Article -
2
Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies
Published in Journal of Nuclear Medicine (01-08-2018)“…Since the first clinical use of 131I-labeled prostate-specific membrane antigen (PSMA), xerostomia has been identified as a relevant side effect of PSMA…”
Get full text
Journal Article -
3
Erdheim-Chester Disease: The Importance of Information Integration
Published in Case reports in oncology (11-07-2017)“…Background: Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis disorder that utilizes the RAS-RAF-MEK-ERK pathway. It has a highly…”
Get full text
Journal Article -
4
PSMA‐Hornet: Fully‐automated, multi‐target segmentation of healthy organs in PSMA PET/CT images
Published in Medical physics (Lancaster) (01-02-2024)“…Background Prostate‐specific membrane antigen (PSMA) PET imaging represents a valuable source of information reflecting disease stage, response rate, and…”
Get full text
Journal Article -
5
The Role of FDG PET in Diabetic Myonecrosis: A Rare and Underrecognized Complication of Diabetes
Published in Clinical nuclear medicine (01-02-2018)“…ABSTRACTA 66-year-old man with poorly controlled type 2 diabetes was admitted for acute bilateral calf pain in the context of coronary artery disease, chronic…”
Get full text
Journal Article -
6
Ureteral Metastasis From Prostate Cancer: A PSMA PET Pitfall
Published in Clinical nuclear medicine (01-09-2020)“…ABSTRACTA 72-year-old man with a history of prostate adenocarcinoma initially managed by radical prostatectomy and salvage radiation therapy underwent…”
Get full text
Journal Article -
7
Asthmatic Exacerbation as a Cause of False-Positive Whole-Body Iodine Scan in a Patient With Treated Papillary Thyroid Carcinoma
Published in Clinical nuclear medicine (01-04-2018)“…ABSTRACTA 44-year-old woman was found to have new diffuse lung uptake on a follow-up whole-body I scan 1 year after being treated with surgery and radioactive…”
Get full text
Journal Article -
8
Diagnostic performance of [.sup.18]F-DCFPyL positron emission tomography/computed tomography for biochemically recurrent prostate cancer and change-of-management analysis
Published in Canadian Urological Association journal (01-06-2021)“…Introduction: Conventional imaging (CI) performs poorly to identify sites of disease in biochemically recurrent prostate cancer. [.sup.68]Ga-PSMA-11 positron…”
Get full text
Journal Article -
9
18F-fluorodeoxyglucose positron emission tomography/computed tomography in extensive bland portal vein thrombosis from retroperitoneal adenocarcinoma
Published in World journal of nuclear medicine (01-04-2019)“…Abstract A 73-year-old woman undergoing hormone therapy for previously treated localized breast cancer presented at oncology follow-up 4 years after…”
Get full text
Journal Article -
10
Incidental Hydroxyapatite Ocular Implant Uptake on Bone Scan Done for Prostate Cancer Staging: Case Report and Brief Review
Published in Molecular imaging and radionuclide therapy (01-06-2019)“…A 74-year-old man recently diagnosed with high-risk prostate cancer with high serum prostate specific antigen was referred to nuclear medicine for a…”
Get full text
Journal Article -
11
I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy
Published in Molecular imaging and radionuclide therapy (01-06-2018)“…Radioactive iodine (RAI) treatment of differentiated thyroid cancer has been used in clinical practice for almost 60 years and is generally accepted to be a…”
Get full text
Journal Article -
12
The Elusive Neuroendocrine Tumor: Finding the Ectopic ACTH Source 16 Years After the Diagnosis of Cushing Syndrome
Published in JCEM case reports (07-02-2023)“…Ectopic adrenocorticotropin hormone (ACTH) syndrome (EAS) accounts for the minority of cases of Cushing syndrome. Up to 20% of these cases remain occult,…”
Get full text
Journal Article -
13
Temperament and character personality dimensions in nitrate-tilt-induced vasovagal syncope patients
Published in Hellenic journal of cardiology (01-11-2017)“…Vasovagal syncope (VVS) is a clinical syndrome that is characterized by a transient loss of consciousness and postural tone that are due to a temporary,…”
Get full text
Journal Article -
14
Differential Uptake Volume Histograms as a Predictor of Response in Rectal Adenocarcinoma Patients Treated with Preoperative Endorectal Brachytherapy
Published in Brachytherapy (01-05-2017)Get full text
Journal Article -
15
Incidental Hydroxyapatite Ocular Implant Uptake on Bone Scan Done for Prostate Cancer Staging: Case Report and Brief Review/Prostat Kanseri Evrelemesi icin Yapilan Kemik Sintigrafisinde Okuler Implantta Insidental Hidroksiapatit Tutulumu: Olgu Sunumu ve Kisa Ozet
Published in Molecular imaging and radionuclide therapy (01-06-2019)“…A 74-year-old man recently diagnosed with high-risk prostate cancer with high serum prostate specific antigen was referred to nuclear medicine for a…”
Get full text
Journal Article -
16
I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy: Diferansiye Tiroid Kanser Tedavisinde I-131 Radyasyona Bagli Miyelosupresyon
Published in Molecular imaging and radionuclide therapy (01-06-2018)“…Radioactive iodine (RAI) treatment of differentiated thyroid cancer has been used in clinical practice for almost 60 years and is generally accepted to be a…”
Get full text
Journal Article -
17
Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18 F PET/CT in prostate cancer patients in early biochemical failure
Published in Nuclear medicine communications (01-03-2023)“…Prostate-specific membrane antigen (PSMA) positron emission tomography/computer tomography (PET/CT) in prostate cancer patients with biochemical failure(BCF)…”
Get full text
Journal Article -
18
-
19
Small Lymph Node Metastasis Detected by 68Ga–Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low–Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer
Published in Clinical nuclear medicine (01-04-2018)“…ABSTRACTA 58-year-old man with Gleason 4+3 prostate cancer was initially treated by radical prostatectomy followed by salvage radiotherapy to the prostate bed…”
Get full text
Journal Article -
20